Radiotherapy or CDK4/6 inhibitors abolish Rb phosphorylation, with the aim to induce cell cycle arrest in tumor cells, which undesirably also contributes to tumor immune evasion by enhancing PD-L1 expression [42]. This evidence concerns the gene RB1 and neoplasm.